143 Pre-eclampsia, we know little and are doing nothing

Introduction Pre-eclampsia (PE) is one of the biggest causes for maternal mortality in the world. Identifying risk groups and using acetylsalicylic acid (AAS) and calcium (Ca) are pointed as important measures in the attempt to reduce maternal and fetal morbidity. Aim To assess, among patients with PE, the percentage of risk factors (RF) identifiable and to verify, among them, how many have used some prevention method. Methodology it were evaluated medical records and prenatal cards of all patients that have developed PE (n = 50) between January and May 2016. Also, a targeted questionnaire was applied to identify the RF and the use of some preventive medication for PE. It were considered RF: primiparity, previous PE history, chronic arterial hypertension, pre-existent kidney disease, thrombophilias, autoimmune diseases, multiple pregnancy, PE family history, diabetes mellitus, obesity and advanced maternal age. All patients have signed a free informed consent. Results The results are presented in the attached table. The vast majority of patients with PE (90%) had some RF identifiable during prenatal and a great part (86%) presented more than one. However, it was observed a small prescription rate of AAS and/or Ca in this population. Conclusion We have observed that among patients with PE, the RF presence is considerable. We also have observed a low prescription of AAS and Ca in this population. PE is a potentially fatal pathology and the interventions in an attempt to prevent its arising are few. We have verified that despite they exist, they are not used in the routine practice. Actions for making the assisting team more conscious shall be employed, as well as disseminating the scientific knowledge in a more comprehensive form. Download : Download high-res image (512KB) Download : Download full-size image